INICIO

Continuation of the Revista Mexicana de Cardiología

    
  • Home
  • Instructions for authors
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • Contact





2022, Number 2

Cardiovasc Metab Sci 2022; 33 (2)

Usefulness of echocardiography in athletes: experience of a Portuguese center

Dias, Geraldo; Von Hafe, Pedro; Cardoso, Filipa; Pereira, Tamara; Tinoco, Mariana; Português, João; Lourenço, António

ABSTRACT

Introduction: Pre-participation screening aimed at the detection of disorders associated with sudden cardiac death is universally supported by major medical societies. However, the best method for screening remains controversial. The aim of this study was to evaluate the prevalence of structural cardiac lesions identified by echocardiography in apparently healthy athletes referred for pre-participation screening. Material and methods: We conducted an observational retrospective study (January 2017-December 2019) performed in a single center. We evaluated echocardiograms of athletes under 35 years of age, performed in the first evaluation for pre-participation screening. Results: A total of 1,981 different athletes' echocardiograms were included; 36 exams (1.8%) reported structural cardiac lesions. The most common cardiac lesions found were mitral valve prolapse (n = 5), atrial septal aneurysm (n = 5) and atrial septal defect (n = 4). The bicuspid aortic valve and left ventricular hypertrophy were each present in 3 athletes (n = 3); ventricular septal defects, left ventricular noncompaction, aortic dilatation and dilated cardiomyopathy were each found in 2 athletes (n = 2). Less frequent lesions were present in only one athlete, such as hypertrophic cardiomyopathy, surgically-corrected transposition of the great arteries, and pulmonary valve stenosis. Notably, among 36 patients with structural abnormalities in echocardiography, only 6 (16.7%) had positive standard pre-participation screening (combining personal and family history, physical examination and electrocardiogram). Conclusions: Echocardiography plays an important role in detecting cardiac structural abnormalities that would otherwise escape standard screening protocols and could be left unnoticed. This study suggests a potential benefit of including echocardiography in the first evaluation for pre-participation screening of competitive athletes.
  FULL TEXT PDF  

Keywords

Electrocardiogram echocardiography athlete pre-participation screening sudden cardiac death




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Usefulness of echocardiography in athletes: experience of a Portuguese center
    2022, Vol.33, Núm. 2
  • Difficult diagnosis infective endocarditis in a pediatric patient: case report
    2022, Vol.33, Núm. 2
  • Economic evaluation of evolocumab in uncontrolled patients with high-risk...
    2022, Vol.33, Núm. 2
  • Case report: COVID-19 mRNA vaccine association with acute myocarditis
    2022, Vol.33, Núm. 2
  • Cacao phytochemicals in the prevention of death from cardiovascular disease:...
    2022, Vol.33, Núm. 2
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2


Cardiovascular and Metabolic Science Vol. 33, Num. 2, Abril-Junio 2022. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: EN TRÁMITE. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 1 de julio de 2022.

 

2022     |     https://www.cardiovascularandmetabolicscience.org.mx/